T1	Outcomes 197 257	efficacy (maintenance of remission), safety and tolerability
T2	Outcomes 1071 1108	Relapse-free survival; number of N.S.
T3	Outcomes 1109 1282	relapses/patient/year; cumulative dose of prednisone/patient; laboratory investigations (kidney and liver functions, haematological parameters); incidence of adverse events.
T4	Outcomes 1347 1365	complete remission
T5	Outcomes 1402 1420	partial remission;
T6	Outcomes 1472 1490	complete remission
T7	Outcomes 1503 1520	partial remission
T8	Outcomes 1609 1624	risk of relapse
T9	Outcomes 1787 1819	mean number of relapses per year
T10	Outcomes 1833 1860	dose of prednisone per year
T11	Outcomes 2136 2150	relapse of NS.
T12	Outcomes 2151 2160	Tolerance
T13	Outcomes 2202 2226	CsA-related side-effects
T14	Outcomes 2406 2424	stable remissions.
